NGM282, A NOVEL SPECIFIC INHIBITOR OF CYP7A1-MEDIATED BILE ACID SYNTHESIS, IS SAFE AND WELL TOLERATED WITH PREDICTABLE PHARMACOKINETICS IN HEALTHY HUMAN SUBJECTSS. Rossi, K. Allamneni, M. Elliott,K. Byrnes-Blake,J. Luo,L. Ling, H. Tian,A. De PaoliJournal of Hepatology（2014）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
